- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03707431
Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis
March 20, 2026 updated by: Tonya Palermo, Seattle Children's Hospital
A Randomized Trial of a Web-based Non-pharmacological Pain Intervention for Pediatric Chronic Pancreatitis
Abdominal pain is common in children with chronic and acute recurring pancreatitis (CP, ARP), and as they continue into adulthood, the disease progresses with increased pain and greater exposure to opioids.
Despite the relevancy of early pain self-management for childhood pancreatitis, there have been no studies of non-pharmacological pain intervention in this population.
The proposed project will evaluate a web-based cognitive behavioral pain management program delivered to a cohort of well-phenotyped children with CP/ARP and some community participants to reduce pain, pain-related disability and enhance HRQOL; it will also identify genetic risk factors and clinical and behavioral phenotypic factors associated with treatment response to enable precision medicine approaches.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Abdominal pain is present in 81% of children and adolescents with CP and ARP.
Effective treatments that target pain in these children will lessen the risk of opioid exposure and continued pain and disability into adulthood.
We plan to recruit a large multicenter sample of 260 children and adolescents (ages 10-19 years) with CP/ARP and their parents from INSPPIRE 2 (INSPPIRE:INternational Study Group of Pediatric Pancreatitis: In search for a cuRE) centers and pancreatitis community groups (e.g.
NPF) to evaluate the efficacy of WebMAP, a web-based cognitive behavioral pain management program (CBT).
The study design is a two (group) x three (time point) randomized, controlled, double-blinded trial.
Participants will be randomly assigned to receive online access to either pain education (WebED) or CBT (WebMAP) over an 8-10 week treatment period.
The primary study outcome is abdominal pain symptoms measured at pre-treatment, immediately post-treatment, and at 6-month follow-up.
Secondary outcomes include pain-related disability, health-related quality of life, depression and anxiety symptoms, and medication use.
This project represents a significant advance in pain management for children with CP/ARP by evaluating the first ever nonpharmacologic pain intervention in these patients, which may guide future developments in the management of chronic pain associated with CP/ARP.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98105
- Seattle Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 19 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with CP or ARP
- ages 10-19 years
- at least 4 acute pancreatitis flare-ups/attacks in past year, or at least 1 instance of moderate (4/10 pain) pancreatitis/abdominal pain in the past month
- access to the Internet on any web-enabled device
Exclusion criteria:
- non-English speaking
- inability to read at the 5th grade level due to learning problem or developmental delay
- children with cystic fibrosis who have pancreatic insufficiency at the time of diagnosis
- patients with Shwachman-Bodian-Diamond Syndrome
- Acute Recurrent Pancreatitis (ARP) with no evidence of chronic or persistent pain
- anticipated surgery (TPIAT or other) during study participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Web-based CBT (WebMAP)
Receives access to WebMAP
|
The eight child modules include: 1) education about chronic pain, 2) recognizing stress and negative emotions, 3) deep breathing and relaxation, 4) implementing coping skills at school, 5) cognitive skills (e.g., reducing negative thoughts), 6) lifestyle interventions, 7) staying active (e.g., pleasant activity scheduling), 8) relapse prevention.
The eight parent modules are: 1) education about chronic pain, 2) recognizing stress and negative emotions, 3) operant strategies I (using attention and praise to increase coping), 4) operant strategies II (using rewards to increase positive coping and reach school goals), 5) modeling, 6) lifestyle, 7) communication, 8) relapse prevention.
Other Names:
|
|
Active Comparator: Pain Education (WebED)
Receives access to WebED
|
The pain education website provides publicly available educational information about pancreatitis and abdominal pain.
There is general information about pancreatitis from available web sources (e.g., National Pancreas Foundation) as well as information about chronic pain in childhood.
The content does not include any instruction in the behavioral and cognitive skills taught within the WebMAP program.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Adolescent Abdominal Pain Severity
Time Frame: Baseline, 12 weeks, 6 months
|
The Abdominal Pain Index (API) assesses characteristics of abdominal pain during the previous 2 weeks including the number of days with pain, number of pain episodes per day, typical pain episode duration, and typical pain intensity.
An index is computed with higher scores indicating greater abdominal pain severity.
A mean score is reported on a scale of 0 to 4, where higher values indicate more severe (worse) abdominal pain severity.
|
Baseline, 12 weeks, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pain-related Disability
Time Frame: Baseline, 12 weeks, 6 months
|
The Child Activity Limitations Interview (CALI-9) is a daily diary validated to assess perceived difficulty in completing 9 daily activities as a measure of pain-related disability.
Responses are rated on a 5-point scale (0-4) with higher scores indicating greater perceived difficulty with activities.
Youth will provide ratings daily for 7 days on their online diaries at each assessment period.
Mean total activity limitations across the reporting period is used in analyses, with higher scores indicating greater disability.
The maximum possible total score is 36.
|
Baseline, 12 weeks, 6 months
|
|
Change in Health-related Quality of Life
Time Frame: Baseline, 12 weeks, 6 months
|
The Pediatric Quality of Life Inventory (Peds-QL) assesses several domains of functioning, including physical, social, emotional, and academic functioning.
The PedsQL is widely used as it demonstrates good reliability for both the parent and child self-report measures.
Higher scores indicate fewer difficulties (better) health-related quality of life.
Sub scales of physical and psychosocial health will be used in analyses.
All scales range from 0 to 100.
|
Baseline, 12 weeks, 6 months
|
|
Change in Emotional Distress
Time Frame: Baseline, 12 weeks, 6 months
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Emotional Distress Scales include an 8-item scale of anxiety (Pediatric v2.0 SF8a Anxiety) that assesses fear (e.g., fearfulness), anxious misery (e.g., worry) and hyperarousal (e.g., nervousness) and 8-item scale of depressive symptoms (Pediatric v2.0 SF8a Depressive Symptoms) that evaluates negative mood, view of self and social cognitions.
Raw scores and T-scores are computed with T-scores above 60 indicating clinically elevated (worse) symptoms.
The general population mean T-score is 50, with a standard deviation of 10.
Anxiety T-scores range from 33.5-83.3,
and depression T-scores range from 35.2-82.4.
|
Baseline, 12 weeks, 6 months
|
|
Change in Opioid Use
Time Frame: Baseline, 6 months
|
Over the counter and prescription (opioid and non-opioid) medication use in the preceding 7 days.
|
Baseline, 6 months
|
|
Change in Pain Self-efficacy
Time Frame: Baseline, 12 weeks, 6 months
|
The Pain Self-Efficacy Scale is a 7-item measure that assesses the child's beliefs in carrying out activities when in pain.
The scale has demonstrated good internal consistency, cross-informant reliability with parent report, and strong construct validity.
Higher scores (score range 7-35) indicate higher self-efficacy.
|
Baseline, 12 weeks, 6 months
|
|
Change in Parent Impact of Pain
Time Frame: Baseline, 12 weeks, 6 months
|
Parents will complete the Bath Adolescent Pain Questionnaire-Parent Impact Questionnaire (BAPQ-PIQ), a measure of the impact of parenting an adolescent with chronic pain.
The BAPQ-PIQ is a 62-item questionnaire with 8 scales including: depressive symptoms, anxiety, pain catastrophizing, self-blame, partner relationship, social (leisure) functioning, parental behavior, and parental role strain.
Items are rated on a 5-point frequency response scale (0 = never, 4 = always) with higher scores indicating more impaired (worse) functioning for all subscales.
The BAPQ-PIQ has demonstrated good reliability and validity among parents of youth with chronic pain.
Sub scales will be analyzed separately.
For brevity given the number of time points and subscales, the depression (range: 0-36) and anxiety (range: 0-24) subscales are reported here.
|
Baseline, 12 weeks, 6 months
|
|
Change in Pain Interference
Time Frame: Baseline, 12 weeks, 6 months
|
The PROMIS Pain Interference - v2.0 Pediatric Short Form 8a includes 8 items to assess consequences of pain on relevant aspects of one's life.
This includes the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities.
The scale has been validated in pediatric patients with chronic pain.
Raw scores and T-scores are computed with T-scores above 60 indicating clinically elevated (worse) symptoms.
T-scores range from 34-78.
The general population mean T-score is 50, with a standard deviation of 10.
|
Baseline, 12 weeks, 6 months
|
|
Change in Health Service Utilization
Time Frame: Baseline, 6 months
|
Parents will complete the Client Service Receipt Inventory-Pain version, a measure of service use, out-of-pocket expenses, and lost work time incurred by families for the evaluation or management of the child's chronic pain.
Questions pertain to hospital admissions, outpatient services, community services (e.g., tutor, lawyer), medications, lost work time, paid help, and other costs.
We will compute the following variables: total number of services used by category, number of lost parental work days, and number of out-of-pocket expenses; visits, medications, other treatments, and indirect costs as reported by the parent.
For brevity, we will report the 2 primary variables used in analysis found to be related to child pain: the number of doctor outpatient service visits and number of emergency dept visits.
|
Baseline, 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tonya Palermo, PhD, Seattle Children's Hospital
- Principal Investigator: Aliye Uc, MD, University of Iowa
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 25, 2019
Primary Completion (Actual)
July 31, 2024
Study Completion (Actual)
July 31, 2024
Study Registration Dates
First Submitted
October 2, 2018
First Submitted That Met QC Criteria
October 12, 2018
First Posted (Actual)
October 16, 2018
Study Record Updates
Last Update Posted (Actual)
April 9, 2026
Last Update Submitted That Met QC Criteria
March 20, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01DK118752-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pancreatitis
-
Changhai HospitalUnknownChronic Pancreatitis | Idiopathic Chronic PancreatitisChina
-
AbbottCompletedExocrine Pancreatic Insufficiency, Chronic PancreatitisJapan
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Postgraduate Institute of Medical Education and...Completed
-
Dartmouth-Hitchcock Medical CenterCompleted
-
The Cleveland ClinicChiRhoClin, Inc.; The National Pancreas FoundationCompletedChronic PancreatitisUnited States
-
Massachusetts General HospitalTerminatedChronic PancreatitisUnited States
-
Winthrop University HospitalCelgene CorporationTerminatedChronic Pancreatitis
-
Changhai HospitalEnrolling by invitationChronic Pancreatitis | Acute Pancreatitis | Healthy PeopleChina
Clinical Trials on Web-based CBT
-
Seattle Children's HospitalCompletedChronic Pain | Headache | Central SensitisationUnited States
-
Oregon Research InstituteNational Institute of Mental Health (NIMH)CompletedPostpartum DepressionUnited States, Australia
-
University of California, San FranciscoCompleted
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA); Beth Israel Medical CenterCompleted
-
University of South FloridaRecruitingDementia | Insomnia ChronicUnited States
-
National Development and Research Institutes, Inc.Syracuse VA Medical Center; The VA Western New York Healthcare SystemUnknownPost-Traumatic Stress Symptoms | Problematic Use of Alcohol or Other DrugsUnited States
-
Boston UniversityPatient-Centered Outcomes Research InstituteCompleted
-
Syracuse VA Medical CenterNational Development and Research Institutes, Inc.CompletedSubstance Use Disorders | Stress Disorders, Post-traumaticUnited States
-
Umeå UniversitySwedish Council for Working Life and Social Research; Jämtland County Council... and other collaboratorsCompletedFemale Stress Urinary IncontinenceSweden
-
Seattle Children's HospitalUniversity of VirginiaActive, not recruitingMigraine Disorders | Insomnia | Headache DisordersUnited States